share_log

Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.

Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.

Aerpio製藥公司股價上漲,此前HC Wainwright&Co.將該公司股票評級從中性上調至買入,並宣佈了22美元的目標價。
Benzinga ·  2021/07/08 09:18

Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.

Aerpio製藥公司股價上漲,此前HC Wainwright&Co.將該公司股票評級從中性上調至買入,並宣佈了22美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論